Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rappuoli

Showing results (271-280 of 314) with videos related to

Pageof 32
Sort By:
Infection and Immunity|March 1, 1995
Helicobacter pylori-specific CD4+ T-cell clones from peripheral blood and gastric biopsiesA Di Tommaso, Z Xiang, M Bugnoli, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplicationA Nicosia, M Perugini, C Franzini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
The binding subunit of pertussis toxin inhibits HIV replication in human macrophages and virus expression in chronically infected promonocytic U1 cellsM Alfano, G Vallanti, P Biswas, et al.
Vaccine|March 21, 2001
Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvantsM Pizza, M M Giuliani, M R Fontana, et al.
Infection and Immunity|November 1, 1995
Helicobacter pylori cytotoxin: importance of native conformation for induction of neutralizing antibodiesR Manetti, P Massari, D Burroni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1994
Pertussis toxin interferes with superantigen-induced deletion of peripheral T cells without affecting T cell activation in vivo. Inhibition of deletion and associated programmed cell death depends on ADP-ribosyltransferase activityJ A Gonzalo, A González-García, E Baixeras, et al.
Vaccine|January 4, 2001
A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal deliveryE A McNeela, D O'Connor, I Jabbal-Gill, et al.
The Journal of Infectious Diseases|March 10, 2001
Helicobacter pylori neutrophil-activating protein stimulates tissue factor and plasminogen activator inhibitor-2 production by human blood mononuclear cellsP Montemurro, G Barbuti, W G Dundon, et al.
The Journal of Pediatrics|May 1, 1992
Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: safety and immunogenicity in 12- to 24- and 2- to 4-month-old childrenA Podda, E C De Luca, L Titone, et al.
Biophysical Journal|February 27, 1999
Helicobacter pylori vacuolating toxin forms anion-selective channels in planar lipid bilayers: possible implications for the mechanism of cellular vacuolationF Tombola, C Carlesso, I Szabò, et al.
Pageof 32

Showing results (271-280 of 314) with videos related to

Sort By:
Pageof 32
Infection and Immunity|March 1, 1995
Helicobacter pylori-specific CD4+ T-cell clones from peripheral blood and gastric biopsiesA Di Tommaso, Z Xiang, M Bugnoli, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplicationA Nicosia, M Perugini, C Franzini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
The binding subunit of pertussis toxin inhibits HIV replication in human macrophages and virus expression in chronically infected promonocytic U1 cellsM Alfano, G Vallanti, P Biswas, et al.
Vaccine|March 21, 2001
Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvantsM Pizza, M M Giuliani, M R Fontana, et al.
Infection and Immunity|November 1, 1995
Helicobacter pylori cytotoxin: importance of native conformation for induction of neutralizing antibodiesR Manetti, P Massari, D Burroni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1994
Pertussis toxin interferes with superantigen-induced deletion of peripheral T cells without affecting T cell activation in vivo. Inhibition of deletion and associated programmed cell death depends on ADP-ribosyltransferase activityJ A Gonzalo, A González-García, E Baixeras, et al.
Vaccine|January 4, 2001
A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal deliveryE A McNeela, D O'Connor, I Jabbal-Gill, et al.
The Journal of Infectious Diseases|March 10, 2001
Helicobacter pylori neutrophil-activating protein stimulates tissue factor and plasminogen activator inhibitor-2 production by human blood mononuclear cellsP Montemurro, G Barbuti, W G Dundon, et al.
The Journal of Pediatrics|May 1, 1992
Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: safety and immunogenicity in 12- to 24- and 2- to 4-month-old childrenA Podda, E C De Luca, L Titone, et al.
Biophysical Journal|February 27, 1999
Helicobacter pylori vacuolating toxin forms anion-selective channels in planar lipid bilayers: possible implications for the mechanism of cellular vacuolationF Tombola, C Carlesso, I Szabò, et al.
Pageof 32